Description
Evrizam Capsules
Composition
Each capsule contains Piracetam 400 mg and Cinnarizine 25 mg.
Mechanism of Action
Piracetam enhances memory and cognitive function by improving cellular membrane fluidity and neurotransmitter release. Cinnarizine acts as a calcium channel blocker, reducing vertigo and enhancing cerebral blood flow.
Pharmacological Properties
Evrizam capsules combine the cognitive-enhancing properties of Piracetam with the vestibular suppressant effects of Cinnarizine, providing a synergistic action to improve cognitive function, reduce vertigo, and enhance cerebral blood flow.
Indications for Use
Evrizam capsules are indicated for improving cognitive function, reducing vertigo, and enhancing cerebral blood flow.
Contraindications
Avoid using Evrizam capsules if allergic to any of the ingredients, pregnant, or breastfeeding without medical advice.
Side Effects
Common side effects may include gastrointestinal discomfort. Discontinue use and seek medical attention if any adverse reactions occur.
Usage Instructions
Take 1 capsule orally twice a day, or as directed by a healthcare professional. Swallow the capsules whole with water and preferably with meals to minimize gastrointestinal side effects.
Benefits Compared to Analogues
Evrizam capsules offer a unique combination of Piracetam and Cinnarizine, providing both cognitive-enhancing and vestibular suppressant effects in a single formulation, leading to improved cognitive function, reduced vertigo, and enhanced cerebral blood flow compared to individual analogues.
Suitable Patient Groups
Evrizam capsules are suitable for adult patients seeking cognitive enhancement, vertigo reduction, and improved cerebral blood flow. Consult a healthcare professional for use in specific patient groups such as children or the elderly.
Storage and Shelf Life
Store Evrizam capsules in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired capsules.
Packaging Description
Evrizam capsules are available in a package containing 60 capsules.
Clinical Evidence and Proven Effectiveness
Piracetam and Cinnarizine have been extensively studied for their cognitive-enhancing and vestibular suppressant properties. Clinical trials have shown promising results in conditions such as vertigo, dizziness, and cognitive impairment, demonstrating the efficacy and safety of Evrizam capsules in improving symptoms and quality of life.
